Facts abouts Bydureon, Exenatide For injectable Suspension

 

What is Bydureon,  Exenatide For injectable Suspension

BYDUREON is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus and should be used along with diet and exercise.

BYDUREON is a long-acting form of the medication contained in BYETTA. Do not use BYDUREON and BYETTA together.

BYDUREON is not recommended as the first choice of medication for treating diabetes.

BYDUREON is not insulin.

It is not known if BYDUREON is safe and effective when used with insulin.

BYDUREON is not for use in people with type 1 diabetes or people with a condition caused by very high blood sugar (diabetic ketoacidosis).

It is not known if BYDUREON is safe and effective in children. BYDUREON is not recommended for use in children.

It is not known if BYDUREON is safe and effective in people who have a history of pancreatitis.

BYDUREON has not been studied in people who have severe kidney problems.

 

 How To buy is Bydureon,  Exenatide For injectable Suspension

Bydureon (Exenatide) injection suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Bydureon (Exenatide) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

 


What are the Indication and usage ?

BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settingsBYDUREON is an extended-release formulation of exenatide. Do not co-administer with BYETTA.

Limitation of Use:

Not recommended as first-line therapy for patients inadequately controlled on diet and exercise

Should not be used to treat type 1 diabetes or diabetic ketoacidosis

Use with insulin has not been studied and is not recommended

Has not been studied in patients with a history of pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis

 

Dosage and Forms And strengths of Bydureon (Exenatide)

Available as (Form & Strength): 2 mg exenatide for extended-release injectable suspension.

 

Why is Bydureon being discontinued?

On September 14, 2020, AstraZeneca announced that the Byduron (exenatide) pen would be discontinued by March 2021 for commercial reasons. - Discontinuation is not due to safety or efficacy issues, product quality or manufacturing concerns. The Bydureon BCise® (exenatide) Pen will remain available.

 

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·         ...
Read more

The BEST HIV MEDICINE DISTRIBUTOR IN DELHI

Image
  If you're in search of an HIV medication distributor in Delhi, you've come to the right place. There are many options to choose from - NCPI+,Alleviareindia. GSNP+ and a few other brands. Here are some factors to consider. NCPI+ The NCPI+ HIV MEDICINE DISRIBUTOR IN DELHI works to provide HIV medications to people in need in the country. The medicines are incredibly expensive in the open market. However, the government is providing free antiretroviral drugs to 2.1 million people in India. The government procures these drugs through a tender process. The medicines are not readily available at the patient's home, so they need to be transported to the person who needs it most. There are several reasons for this. First, people need to be protected from police. While traveling, they need to present a pass issued by the government or a state AIDS control society. In some cases, police have torn people's green books, forcing them to go without access to the medicines. This has...
Read more

What is Byduron? What are their Side Effects?

Image
What is Bydureon (exenatide)? Bydureon is a brand-name medicine used to improve blood sugar levels in people with type 2 diabetes. It comes as a liquid suspension to be given by injection under the skin (subcutaneously). Bydureon contains a medicine called extended-release exenatide. Bydureon vs Bydureon BCise Bydureon BCise is another form of Bydureon. It contains the same medicine (extended-release exenatide). Bydureon and Bydureon BCise work in the same way and have very similar effects in the body. You push the autoinjector against your skin, and it injects the medicine automatically. There are fewer steps required to inject Bydureon using this autoinjector than using a syringe or pen injector. This can make Bydureon BCise easier to use than Bydureon. In clinical studies, Bydureon reduced hemoglobin A1c (HbA1c) by approximately 0.88 to 1.6 percent after 24 to 28 weeks of treatment. In the Bydureon BCise study, HbA1c was reduced by approximately 1.07 to 1.39 percent after ...
Read more